Evidence map›Paper›PMID 29638216›Full record

ArticleeLife2018

An efficient and scalable pipeline for epitope tagging in mammalian stem cells using Cas9 ribonucleoprotein.

Pooran Singh Dewari, Benjamin Southgate, Katrina Mccarten, German Monogarov, Eoghan O'Duibhir, Niall Quinn, Ashley Tyrer, Marie-Christin Leitner, Colin Plumb, Maria Kalantzaki and 10 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. CRISPR Gene Tagging for Illuminating Endogenous Protein Dynamics.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 3 countries.

Pooran Singh DewariEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Benjamin SouthgateEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Katrina MccartenEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
German MonogarovGerman Cancer Research Center, University of Heidelberg, Heidelberg, Germany.
Eoghan O'DuibhirEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Niall QuinnInstitute of Genetics and Molecular Medicine, Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Ashley TyrerEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Marie-Christin LeitnerEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Colin PlumbEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Maria KalantzakiEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Carla BlinEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Rebecca FinchEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Raul Bardini BressanEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0002-5673-9563
Gillian MorrisonEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Ashley M JacobiIntegrated DNA Technologies, Inc., Coralville, United States.
Mark A BehlkeIntegrated DNA Technologies, Inc., Coralville, United States.
Alex von KriegsheimInstitute of Genetics and Molecular Medicine, Edinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Simon TomlinsonEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.
Jeroen KrijgsveldGerman Cancer Research Center, University of Heidelberg, Heidelberg, Germany.
Steven M PollardEdinburgh Cancer Research United Kingdom Centre, University of Edinburgh, Edinburgh, United Kingdom.ORCID http://orcid.org/0000-0001-6428-0492
Edinburgh Cancer Research · GBGerman Cancer Research Center · DEIntegrated DNA Technologies (United States) · US

Funding

Biotechnology and Biological Sciences Research Council BB/M018040/1Cancer Research UK 17368Cancer Research UK 21992Cancer Research UK A17368Medical Research Council BB/M018040/1Medical Research Council MR/K017047/1
6 · The paper itself

Abstract

CRISPR/Cas9 can be used for precise genetic knock-in of epitope tags into endogenous genes, simplifying experimental analysis of protein function. However, Cas9-assisted epitope tagging in primary mammalian cell cultures is often inefficient and reliant on plasmid-based selection strategies. Here, we demonstrate improved knock-in efficiencies of diverse tags (V5, 3XFLAG, Myc, HA) using co-delivery of Cas9 protein pre-complexed with two-part synthetic modified RNAs (annealed crRNA:tracrRNA) and single-stranded oligodeoxynucleotide (ssODN) repair templates. Knock-in efficiencies of ~5-30%, were achieved without selection in embryonic stem (ES) cells, neural stem (NS) cells, and brain-tumor-derived stem cells. Biallelic-tagged clonal lines were readily derived and used to define Olig2 chromatin-bound interacting partners. Using our novel web-based design tool, we established a 96-well format pipeline that enabled V5-tagging of 60 different transcription factors. This efficient, selection-free and scalable epitope tagging pipeline enables systematic surveys of protein expression levels, subcellular localization, and interactors across diverse mammalian stem cells.

Indexed as

CRISPR-Cas SystemsHigh-Throughput Screening AssaysAnimalsBrain NeoplasmsCells, CulturedCRISPR-Associated Protein 9Embryonic Stem CellsEpitope MappingGene EditingHumansMiceNeoplastic Stem CellsNeural Stem CellsOligodeoxyribonucleotidesRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsCRISPR-Associated Protein 9OligodeoxyribonucleotidesRibonucleoproteinsRNA, Guide, CRISPR-Cas SystemsTranscription Factorscell biologyCRISPRdevelopmental biologyepitope tagginggenome editinghumanmouseneural stem cellstem cellstranscription factors

Identifiers

PMID29638216
PMCPMC5947990
OpenAlexW2789884744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.